-
Mashup Score: 85
Osteoporosis is a substantial health concern worldwide, particularly among individuals with advanced chronic kidney disease (CKD). In this population, bone fragility is a prevalent complication attributable to disruptions in mineral and hormonal equilibria, leading to a non-vertebral-fracture risk that is 4 to 6 times higher than that of matched control individuals.1
Source: www.thelancet.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 83
Osteoporosis is a substantial health concern worldwide, particularly among individuals with advanced chronic kidney disease (CKD). In this population, bone fragility is a prevalent complication attributable to disruptions in mineral and hormonal equilibria, leading to a non-vertebral-fracture risk that is 4 to 6 times higher than that of matched control individuals.1
Source: www.thelancet.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 83
Osteoporosis is a substantial health concern worldwide, particularly among individuals with advanced chronic kidney disease (CKD). In this population, bone fragility is a prevalent complication attributable to disruptions in mineral and hormonal equilibria, leading to a non-vertebral-fracture risk that is 4 to 6 times higher than that of matched control individuals.1
Source: www.thelancet.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 83
Osteoporosis is a substantial health concern worldwide, particularly among individuals with advanced chronic kidney disease (CKD). In this population, bone fragility is a prevalent complication attributable to disruptions in mineral and hormonal equilibria, leading to a non-vertebral-fracture risk that is 4 to 6 times higher than that of matched control individuals.1
Source: www.thelancet.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 83
Osteoporosis is a substantial health concern worldwide, particularly among individuals with advanced chronic kidney disease (CKD). In this population, bone fragility is a prevalent complication attributable to disruptions in mineral and hormonal equilibria, leading to a non-vertebral-fracture risk that is 4 to 6 times higher than that of matched control individuals.1
Source: www.thelancet.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 83
Osteoporosis is a substantial health concern worldwide, particularly among individuals with advanced chronic kidney disease (CKD). In this population, bone fragility is a prevalent complication attributable to disruptions in mineral and hormonal equilibria, leading to a non-vertebral-fracture risk that is 4 to 6 times higher than that of matched control individuals.1
Source: www.thelancet.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 83
Osteoporosis is a substantial health concern worldwide, particularly among individuals with advanced chronic kidney disease (CKD). In this population, bone fragility is a prevalent complication attributable to disruptions in mineral and hormonal equilibria, leading to a non-vertebral-fracture risk that is 4 to 6 times higher than that of matched control individuals.1
Source: www.thelancet.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 85
Osteoporosis is a substantial health concern worldwide, particularly among individuals with advanced chronic kidney disease (CKD). In this population, bone fragility is a prevalent complication attributable to disruptions in mineral and hormonal equilibria, leading to a non-vertebral-fracture risk that is 4 to 6 times higher than that of matched control individuals.1
Source: www.thelancet.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 85
Osteoporosis is a substantial health concern worldwide, particularly among individuals with advanced chronic kidney disease (CKD). In this population, bone fragility is a prevalent complication attributable to disruptions in mineral and hormonal equilibria, leading to a non-vertebral-fracture risk that is 4 to 6 times higher than that of matched control individuals.1
Source: www.thelancet.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 81
Osteoporosis is a substantial health concern worldwide, particularly among individuals with advanced chronic kidney disease (CKD). In this population, bone fragility is a prevalent complication attributable to disruptions in mineral and hormonal equilibria, leading to a non-vertebral-fracture risk that is 4 to 6 times higher than that of matched control individuals.1
Source: www.thelancet.comCategories: General Medicine News, EndocrinologyTweet
New—Denosumab in the treatment of #osteoporosis associated with chronic #kidney disease https://t.co/TyTph4JF8F #denosumab #CKD